We have also demonstrated a selective decrease in motor neurons lacking expression of Arg1, and strategies to boost Arg1 expression may also be an appropriate therapeutic target for treatment of human ALS. The gene discussed is ARG1; the disease is amyotrophic lateral sclerosis.